Dr Lal Pathlabs is determined to reach where no diagnostic service provider has ever been By M Neelam Kachhap The mood is upbeat at Dr Lal PathLabs Private Limited (LPL) new lab at Bangalore. Dr Om Prakash Manchanda, Director and CEO, Dr Lal ... Yahoo! India, 4 days ago
Ushering A New Era - Financial Express, 5 days ago
3 images for "dr lal pathlabs"
The public issues of Dr Lal PathLabs and Narayana Hrudayalaya were a huge success as the IPOs oversubscribed multiple times Mumbai: Some successful initial public offers (IPOs) of healthcare firms such as Dr Lal PathLabs Ltd and Narayana Hrudayalaya ...Livemint.com, 2 days ago
Dr. Lal PathLabs settled at Rs 824.15 on BSE, a premium of 49.84% compared to the initial public offer price of Rs 550 on its debut on the bourses today, 23 December 2015. Meanwhile, the S&P BSE Sensex rose 259.65 points or 1.01% to settle at ...Capital Market, 1 month ago Slump continues in Alkem and Dr. Lal Pathlabs on second consecutive day India Infoline, 1 month ago Profit booking drags Dr Lal Pathlabs and Alkem in red India Infoline, 1 month ago Alkem, Dr Lal IPOs spark off Rs 30,000 cr of broker loans Smart Investor, 1 month ago
Healthcare space companies Alkem Laboratories and Dr Lal PathLabs made strong debut on stock exchanges, BSE and NSE, registering big gains over their fixed issue price for the initial public offerings. Investors were rewarded with a return ranging from 30 to ...The Financial Chronicle, 1 month ago Healthcare stocks surge on market debut Nikkei Asian Review, 1 month ago Alkem, PathLabs soar in stellar debut on bourses Economic Times, 1 month ago Sensex gains over 240pts; Alkem, Dr Lal debut 30-32% higher Moneycontrol.com, 1 month ago
This page uses frames, but your browser doesn'tCapital Market, 2 weeks ago Dr Lal PathLabs zooms 50% on debut Business Standard, 1 month ago Shares of Dr. Lal PathLabs Ltd gets listed HDFC Securities, 1 month ago
More from: , Business Standard...and 2 other sources
BSE building, Mumbai.Wikimedia Indian stock markets ended with gains on Wednesday, helped by the absence of large scale selling by foreign institutional investors (FIIs), enabling both Sensex and Nifty to hit their highest levels in three weeks. ...International Business Times India, 1 month ago Dr Lal, Alkem see blockbuster listing, Sensex up 260 pts HT Syndication, 1 month ago Sensex surges 260 points to close at 25,850; Dr Lal climbs 52%, Alkem gains 31% Financial Express, 1 month ago Sensex Ends 260 Points Higher; Dr Lal PathLabs Soars Over 50% on Debut NDTV, 1 month ago
Mehraboon Irani of Nirmal Bang Securities is of the view that Dr Lal PathLabs is a decent bet.Money Control, 3 weeks ago
Shares of drug maker Alkem Laboratories and diagnostic chain operator Dr Lal PathLabs made a strong debut on the bourses on Wednesday, with both opening more than 30 per cent higher than their issue price of Rs 1,050 and Rs 550, respectively. ...Smart Investor, 1 month ago Alkem, Dr Lal soar over 30% on debut Smart Investor, 1 month ago
Rakesh Bansal of RK Global recommends buying Action Construction, Dr Lal Pathlabs, Kaya and Praj Industries.Money Control, 1 month ago
Vijay Chopra of enochventures.com told CNBC-TV18, "I think people for listing gains, have sold the stock of Dr Lal Pathlabs although the company is good and the kind of network this company has across the country and the kind of health awareness ...Moneycontrol.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!